Thus, oncolytic virotherapy appears to be a promising antitumor strategy for inducing autophagy-related death in KRAS/BRAF wild-type and KRAS-mutant CRC cells by suppressing the EGFR-KRAS signaling pathway. The gene discussed is BRAF; the disease is colorectal carcinoma.